We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

This week's business roundup also includes promotions, Missouri manufacturing hall of fame inductees and a public mural ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...

A Stonebridge-led joint venture has won final site plan approval to redevelop a cluster of low-rise commercial buildings in ...

Redevelopment of a former mall, the replacement of a freeway, more hotel rooms and housing are all on the table for ...

This page features the latest news about the Eli Lilly and Co BDR stock. Eli Lilly stock soars to all-time high of $967 amid robust growth Eli Lilly and Co's stock has reached an unprecedented ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

In its motion filed on New Year’s Day ... capacity.” The company also said it seeks to intervene because it does not believe the FDA adequately represents Eli Lilly’s interests.

Eli Lilly (LLY.N), opens new tab has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the agency's decision that Lilly's ...

The anti-obesity drug Zepbound made by Eli ... of New York, US, on Thursday, March 28, 2024. (Photographer: Shelby Knowles/Bloomberg) The anti-obesity drug Zepbound made by Eli Lilly & Co. could ...